Drug maker Pfizer Inc. (PFE) on Thursday posted in-line third quarter profits, although its revenue missed expectations, and unveiled plans for a massive new $10 billion share buyback program.
The New York-based company reported third quarter net income of $3.21 billion, or 43 cents per share, compared with $3.74 billion, or 48 cents per share, in the year-ago period. Excluding special items, adjusted profit was 53 cents per share.
Revenue plunged 16% from last year to $14 billion.
On average, Wall Street analysts expected a matching profit of 53 cents per share, albeit on higher revenue of $14.64 billion.
Looking ahead, PFE lowered its full-year 2012 earnings forecast. The company now expects 2012 earnings of $2.14 to $2.17 per share, down from $2.14 to $2.22 previously.
In another announcement, Pfizer’s board of directors approved plans for a massive new $10 billion share buyback program. The new program is in addition its its current repurchase plan, which currently has about $4.1 billion remaining.
Pfizer shares fell 41 cents, or -1.7%, in premarket trading Thursday.
Pfizer Inc. (PFE) is a “Recommended” dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here